Navigation Links
The Pancreatic Cancer Action Network is Saddened by the Death of NFL Hall of Fame Member Gene Upshaw
Date:8/21/2008

EL SEGUNDO, Calif., Aug. 21 /PRNewswire/ -- The Pancreatic Cancer Action Network (http://www.pancan.org), the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure, is saddened by the loss of NFL Hall of Fame member Gene Upshaw.

"The Pancreatic Cancer Action Network offers its condolences to the Upshaw family and the entire NFL community," said Julie Fleshman, President and CEO. "I know personally the affects this disease has on a family and our thoughts are with them during this difficult time."

Pancreatic cancer is the fourth leading cause of cancer death in the United States, yet is the most under-funded among leading cancer killers with less than 2% of the National Cancer Institutes annual research budget-a figure far to low given the severity of the disease. The incidence among African- American's is 50-90% higher than any other ethnic group in the United States.

"Upshaw's diagnosis and passing reinforces the fact that something must be done to give pancreatic cancer patients a fighting chance," added Fleshman. "We urgently need the funding to find early detection methods, diagnostic tools and ultimately a cure for this disease, which will claim 75% of patients diagnosed this year."

To address this disparity the Pancreatic Cancer Action Network launched Raise the Cure, an unprecedented initiative that combines a commitment to raise $25 million in private funding with a call for the federal government to devote more attention and resources to finding a cure and treatments for pancreatic cancer. The federal component of the plan, called The National Plan to Advance Pancreatic Cancer Research, was developed by the organization's esteemed Scientific Advisory Board, and is a detailed blueprint of the research and federal resources required to make true inroads in this disease.

To learn more about the Pancreatic Cancer Action Network, visit http://www.pancan.org.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research-and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.

The Pancreatic Cancer Action Network fills the void of information and options by giving patients and caregivers reliable, personalized information they need to make informed decisions. We create a sense of hope and community so no one has to face pancreatic cancer alone. The organization helps support individuals and communities all across the country work together to raise awareness and funds to find a cure for pancreatic cancer.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Julie Fleshman http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=75525


'/>"/>
SOURCE Pancreatic Cancer Action Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pancreatic Cancer Biomarkers Found
2. New treatment combination safe for pancreatic cancer patients
3. 3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
4. Beer Drinking May Speed Pancreatic Cancer Onset
5. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
6. The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding
7. Calorie restricted diet prevents pancreatic inflammation and cancer
8. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
9. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
10. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
11. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... , ... September 26, 2017 , ... ... today announced the Atmosera Release Management as a Service (RMaaS) to ... or PaaS environments. Customers include any companies, e-tailers, and web development agencies who ...
(Date:9/26/2017)... ... 26, 2017 , ... Two innovative companies are bringing to ... it is scientifically proven as well: ABAlife™. Euromed SA, a leading manufacturer of ... agreement with BioTherapeutics Inc. for patented technology for absiscic acid (ABA). , ...
(Date:9/26/2017)... ... September 26, 2017 , ... ... John R. Elliott HERO Campaign for Designated Drivers proudly announced the winners of ... Thirty-one local bars and restaurants took on the challenge of competing in three ...
(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The Key ... Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , Consider ... the firm’s electronic records may not be trustworthy and reliable … a more detailed ...
(Date:9/26/2017)... ... September 26, 2017 , ... ... the Chair of the Leg, Ankle, and Foot Section of the Department of ... fellowship trained orthopedic surgeon at Hackensack UMC performing total ankle replacements. Because of ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
Breaking Medicine Technology: